Search

You searched for "therapeutics"

276 results found

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | Ophthalmology
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Inherited retinal disorders now the leading cause of blindness

1 April 2014 | | Retina / Uvea / Vitreous
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

AI breakthrough brings geographic atrophy treatment a step closer

20 September 2021
A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

A life outside ophthalmology

3 April 2023 | | Ophthalmology
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...

Oculomics and Big Data changes the game for Medical Ophthalmologists

25 September 2023 | | oculomics, Nima Ghadiri, big data, ai, artificial intelligence, RETFound, Alastair Denniston
Oculomics and Big Data changes the game for Medical Ophthalmologists, and here's why.

Embracing assistive technology in the fight against sight loss

10 June 2020 | | Ophthalmology, Optometry, ONLINE EXCLUSIVE ARTICLES
The author shares his own experience of sight loss and explains the vital role assistive technology can play in the lives of visually impaired patients. There is no doubt that sight loss continues to be a clear and present danger,...

Quiz Jun/Jul 2024

3 June 2024 | | Ocular Pathology and Oncology, Ophthalmology, Paediatric Ophthalmology / Strabismus
History A one-year-old girl originally presented with a red eye, initially bilaterally and later in the left only. On examination a membrane was found on the tarsal conjunctiva of the upper eyelid (Figure 1). Figure 1: Anterior segment. Serum plasminogen...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy

15 July 2021 | | COVID-19, Ophthalmology, Orbit, Oculoplastics, ONLINE EXCLUSIVE ARTICLES
COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...

NYU Langone Health performs world’s first whole-eye & partial-face transplant

15 November 2023 | NYU Langone, eye transplant, Face transplant, surgery, therapies, Aaron James, USA, Eduardo D. Rodriguez
Landmark whole-eye transplant is a major paradigm shift for potential vision therapies.

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

1 February 2017 | | Retina / Uvea / Vitreous
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...